Moderna decided to develop an mRNA vaccine, and Taiwanese scientist Eric Huang was a key figure.

(Flipping from the website of Harvard University)

[Reporter Yang Yuanting/Taipei Report] Moderna has achieved great success in developing the Wuhan pneumonia vaccine. At the time, Moderna decided to transfer mRNA technology from pharmaceuticals to vaccine development. One of the key figures was Taiwanese scientist Eric Huang. .

On December 23, he will share the stage with Weng Qihui, former dean of the Academia Sinica who developed a broad-spectrum pneumonia mRNA vaccine, and give a speech at Chengda University. This is Huang Yiqun's first public speech in Taiwan.

Come to Taiwan to give a speech on the 23rd

Huang Yiqun, who is currently the general manager and chief scientific officer of Moderna Genomics, a subsidiary of Moderna, immigrated to the United States with his parents when he was 14 years old.

According to Huang Yiqun's resume, he has a Ph.D. in molecular biology and medical parasitology, as well as an MBA degree and can speak fluent Chinese.

Please read on...

After the outbreak of pneumonia in Wuhan, the New Venture Labs team led by Huang Yiqun was an important driving force for Moderna to switch to the development of mRNA vaccines. Lun.

The Warren Alpert Prize recognizes one of five scientists who have contributed to the development of mRNA vaccines.